Bruton Tyrosine Kinase (BTK) inhibitor

News

An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been approved by the US regulator.

News

Novo has moved a step closer to EU approval of its long-acting haemophilia A therapy, Frehemgo, which could be a future blockbuster.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.